News Quantified

ZOM – zomedica corp. common shares (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Zomedica Launches Quantitative Insulin Assay for Equine Plasma on the TRUFORMA(R) Platform [Yahoo! Finance]

Zomedica Launches Quantitative Insulin Assay for Equine Plasma on the TRUFORMA(R) Platform

Sidoti Events, LLC's Virtual November Micro-Cap Conference

Noble Capital Markets Initiates Equity Research Coverage on Zomedica

Zomedica Corp (ZOM) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ... [Yahoo! Finance]

Form 8-K Zomedica Corp. For: Nov 15

Form 4 Zomedica Corp. For: Nov 11 Filed by: POWERS JOHNNY D

Form 4 Zomedica Corp. For: Nov 11 Filed by: Whelan Sean

Form 4 Zomedica Corp. For: Nov 11 Filed by: Rowe Jeffrey M

Form 4 Zomedica Corp. For: Nov 11 Filed by: POWERS JOHNNY D

Top News Gainers

4/8 Zomedica Pharma down 38% premarket after pricing stock offering [Seeking Alpha] 34.1%

2/26 Zomedica Pharmaceuticals Corp. Announces Year End 2019 Financial Results 24.3%

9/11 Zomedica to Present at the Fall Investor Summit on Monday, September 16 in New York City 15.6%

5/20 Form 8-K Zomedica Pharmaceuticals For: May 20 13.0%

8/19 Form 3 Zomedica Pharmaceuticals For: Aug 16 Filed by: POWERS JOHNNY D 9.8%

2/11 Zomedica Files U.S. Patent Application for Fecal Parasite Detection 8.9%

5/10 Zomedica Announces Private Placement of Preferred Shares 8.5%

2/14 Zomedica Announces Completion of $2.5 Million Registered Direct Offering 8.4%

11/3 Zomedica Pharmaceuticals Corp (NYSEAMERICAN) (NYSE: ZOM) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 8.1%

6/10 Zomedica Announces $7 Million Second Tranche Closing of Preferred Shares 6.6%

Top News Decliners

2/12 Zomedica Announces $2.5 Million Registered Direct Offering -38.9%

4/7 Zomedica Pharmaceuticals Corp. Announces Public Offering -20.1%

6/13 Zomedica Announces Completion of Initial Development of a Lymphoma Assay for its Canine Cancer Liquid Biopsy Platform -15.6%

2/21 Form SC 13G Zomedica Pharmaceuticals Filed by: ARMISTICE CAPITAL, LLC -12.2%

5/10 Form 10-Q Zomedica Pharmaceuticals For: Mar 31 -9.1%

3/17 Form 4 Zomedica Pharmaceuticals For: Mar 13 Filed by: Herbst Bruk -8.9%

1/24 Form SC 13D Zomedica Pharmaceuticals Filed by: EQUIDEBT LLC -8.5%

1/22 Form 8-K Zomedica Pharmaceuticals For: Jan 17 -7.7%

2/13 Form 8-K Zomedica Pharmaceuticals For: Feb 12 -6.5%

11/23 Zomedica Pharmaceuticals Corp (NYSEAMERICAN) (NYSE: ZOM) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -6.2%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day